U.S. Hemostats Market Size, Share & Industry Analysis, By Product (Active Hemostats [Thrombin-based Hemostats, and Fibrin Sealants], Passive Hemostats [Plant-based, Animal-based, and Others], Combination Hemostats, and Others), By Application (Trauma, Cardiovascular Surgery, General Surgery, Plastic Surgery, Orthopedic Surgery, Neurosurgery, and Others), By End-user (Hospitals & ASCs, Tactical Combat Casualty Care Centers, and Others), and Country Forecast, 2025-2032

Last Updated: June 09, 2025 | Format: PDF | Report ID: FBI108837

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Number of Key Surgical Procedures in the U.S., 2024
2. Epidemiology of Key Diseases in the U.S., 2024
3. New Product Launches, By Key Players
4. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
5. Impact of COVID-19 on the Market
U.S. Hemostats Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Active Hemostats
    1. Thrombin-based Hemostats
    2. Fibrin Sealants
  2. Passive Hemostats
    1. Plant-based
    2. Animal-based
    3. Others
  3. Combination Hemostats
  4. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Trauma
  2. Cardiovascular Surgery
  3. General Surgery
  4. Plastic Surgery
  5. Orthopedic Surgery
  6. Neurosurgery
  7. Others
3. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals & ASCs
  2. Tactical Combat Casualty Care Centers
  3. Others
Competitive Analysis
1. U.S. Market Share Analysis (2024)
2. Company Profiles
  1. Pfizer Inc.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  2. Johnson & Johnson Services, Inc.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  3. Integra LifeSciences Corporation
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  4. Medtronic
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  5. BD
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  6. Stryker
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  7. Baxter
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  8. Artivion, Inc.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  9. Aegis Lifesciences Private Limited
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.